Xiaofei Wang
6PUBLICATIONS
22CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 09, 2026
CRISPR activation screens identify oncogenic lncRNAs that are susceptible to CDK4/6 inhibitor treatment.Yifei Wang, Yueshan Zhao, Jiaxin Hu
|Aug 18, 2025
Publisher Correction: Cytoplasmic PXR regulates glucose metabolism by binding mRNAs and modulating their stability.Xiaofei Wang, Zehua Wang, Sihan Li
|Aug 12, 2025
Cytoplasmic PXR regulates glucose metabolism by binding mRNAs and modulating their stability.Xiaofei Wang, Zehua Wang, Sihan Li
|Aug 12, 2025
The lncRNA EPIC1 suppresses dsRNA-induced type I IFN signaling and is a therapeutic target to enhance TNBC response to PD-1 inhibition.Dhamotharan Pattarayan, Yue Wang, Zehua Wang
|Dec 08, 2022
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response.Yifei Wang, Yueshan Zhao, Weiwei Guo
Pageof 1
Frequent Collaborators
6 joint publications
Dhamotharan Pattarayan
6 joint publications
Da Yang
5 joint publications
Min Zhang
4 joint publications
Yifei Wang
3 joint publications
Yue Wang
3 joint publications
Yuang Chen
3 joint publications
Wen Xie
3 joint publications
Song Li
2 joint publications
Yueshan Zhao
2 joint publications
Udai S Kammula
